Ionis Pharmaceuticals
IONS
IONS
369 hedge funds and large institutions have $7.3B invested in Ionis Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 124 increasing their positions, 119 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 395 → 369 (-26)
10% less capital invested
Capital invested by funds: $8.14B → $7.3B (-$833M)
38% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 68
Holders
369
Holding in Top 10
6
Calls
$94.6M
Puts
$97.4M
Top Buyers
| 1 | +$56M | |
| 2 | +$26.2M | |
| 3 | +$21.9M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$16.5M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$16.2M |
Top Sellers
| 1 | -$55M | |
| 2 | -$44.1M | |
| 3 | -$41.9M | |
| 4 |
Two Sigma Investments
New York
|
-$39.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$38.5M |